跳至主要内容
临床试验/PACTR202103543569729
PACTR202103543569729已完成未知

Efficacy of perioperative bisoprolol and ivabradine versus bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting

Faculty of Medicine University of Alexandria0 个研究点目标入组 50 人开始时间: 2021年3月7日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • Patients who will be scheduled for coronary artery bypass graft surgery (CABG).

排除标准

  • - Patients with atrial fibrillation or past history of atrial fibrillation.
  • - Concurrent valve surgery or valvular heart diseases (including moderate to severe mitral or aortic regurgitation or stenosis).
  • - Preoperative heart rate of < 50 beats/minute, 2nd or 3rd degrees AV block.
  • - Prior coronary artery bypass graft.
  • - Abnormal renal function with creatinine level (>2mg/dl), end stage renal disease (ESRD) on maintenance dialysis.
  • - Patients on chronic amiodarone or digoxin therapy.
  • - Poor left ventricular function (Ejection fraction < 35 %).
  • - Emergency operation.

研究者

相似试验

已完成
4 期
Effect of Short&#45;term Bisoprolol on Perioperative Myocardial Injury in Patient Undergoing Non&#45;cardiac SurgeryThe patient who undergo abdominal aortic surgeryThe patient who undergo infrainguinal arterial reconstruction surgeryThe patient who undergo non&#45cardiac thoracic surgeryBisoprololPerioperative Myocardial InjuryNon&#45cardiac Surgery
TCTR20180329005The Thailand Research Fund116
进行中(未招募)
1 期
Treatment effects of Bisoprolol and Verapamil in symptomatic patients with non-obstructive hypertrophic cardiomyopathyon-obstructive hypertrophic cardiomyopathy
CTIS2024-515346-17-00Aarhus Universitetshospital140
进行中(未招募)
1 期
The effect of Bisoprolol and Verapamil in non-obstructive hypertrophic cardiomyopathyon-obstructive Hypertrophic cardiomyopathyMedDRA version: 20.0Level: PTClassification code 10007636Term: CardiomyopathySystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: PTClassification code 10049813Term: Non-obstructive cardiomyopathySystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 27.0Level: PTClassification code 10020871Term: Hypertrophic cardiomyopathySystem Organ Class: 10010331 - Congenital, familial and genetic disordersMedDRA version: 20.0Level: LLTClassification code 10061029Term: Cardiomyopathy primarySystem Organ Class: 10007541 - Cardiac disorders
EUCTR2021-006953-77-DKAarhus University Hospital140
已完成
2 期
Evaluation of preventive effect of bisoprolol in sub clinical Heart failure
IRCT20240609062050N1Iran University of Medical Sciences70
已完成
3 期
Evaluation of the effect of bisoprolol in the control of atrial fibrillatioAtrial fibrillation in patients undergoing coronary artery bypass grafting.Atrial fibrillation and flutter
IRCT20210121050095N1Qazvin University of Medical Sciences114
Ivabradine in Prevention of POAF after CABG surgery | 临床试验